PMC:7102662 / 5786-18861
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 8603-8610 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T12 | 385-393 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T13 | 400-405 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T14 | 577-580 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T15 | 838-855 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T16 | 894-903 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T17 | 1089-1094 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T18 | 1210-1215 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T19 | 1220-1225 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T20 | 1286-1295 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T21 | 1474-1478 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T22 | 1612-1620 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T23 | 1767-1776 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
T24 | 2218-2223 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T25 | 2555-2564 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T26 | 4822-4827 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T27 | 5580-5590 | Body_part | denotes | troponin I | http://purl.org/sig/ont/fma/fma62340 |
T28 | 5580-5588 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T29 | 6379-6387 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T30 | 6438-6446 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T31 | 6629-6638 | Body_part | denotes | troponins | http://purl.org/sig/ont/fma/fma62338 |
T32 | 7053-7069 | Body_part | denotes | ribonucleic acid | http://purl.org/sig/ont/fma/fma67095 |
T33 | 7113-7118 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T34 | 7507-7512 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T35 | 7547-7552 | Body_part | denotes | Heart | http://purl.org/sig/ont/fma/fma7088 |
T36 | 8514-8519 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T37 | 8603-8610 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T38 | 8710-8727 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T39 | 10414-10422 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T40 | 10823-10832 | Body_part | denotes | troponins | http://purl.org/sig/ont/fma/fma62338 |
T41 | 11588-11595 | Body_part | denotes | tissues | http://purl.org/sig/ont/fma/fma9637 |
T42 | 11610-11624 | Body_part | denotes | cardiomyocytes | http://purl.org/sig/ont/fma/fma14067 |
T43 | 11687-11692 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T7 | 400-405 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T8 | 838-855 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
T9 | 1210-1215 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T10 | 1474-1478 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T11 | 1667-1673 | Body_part | denotes | organs | http://purl.obolibrary.org/obo/UBERON_0000062 |
T12 | 2218-2223 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T13 | 4822-4827 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T14 | 7113-7118 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T15 | 7507-7512 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T16 | 7547-7552 | Body_part | denotes | Heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T17 | 8710-8727 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T55 | 225-233 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T56 | 258-266 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T57 | 346-356 | Disease | denotes | arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T58 | 360-381 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T59 | 400-413 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T60 | 469-473 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T61 | 535-543 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T62 | 666-676 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T63 | 791-795 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T64 | 818-826 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T65 | 882-890 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T66 | 1020-1028 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T67 | 1057-1063 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T68 | 1065-1073 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T69 | 1370-1378 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T70 | 1479-1485 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T71 | 1506-1518 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T72 | 1541-1549 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T73 | 1648-1654 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T74 | 1685-1703 | Disease | denotes | multiorgan failure | http://purl.obolibrary.org/obo/MONDO_0043726 |
T75 | 1810-1818 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T76 | 1932-1941 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T77 | 2084-2090 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T78 | 2115-2134 | Disease | denotes | coronary thrombosis | http://purl.obolibrary.org/obo/MONDO_0006716 |
T79 | 2124-2134 | Disease | denotes | thrombosis | http://purl.obolibrary.org/obo/MONDO_0000831 |
T80 | 2145-2157 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T81 | 2273-2300 | Disease | denotes | acute myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0004781 |
T82 | 2279-2300 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T83 | 2343-2355 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T84 | 2505-2513 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T85 | 2676-2687 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T86 | 2774-2785 | Disease | denotes | hypokalemia | http://purl.obolibrary.org/obo/MONDO_0003019 |
T87 | 2789-2797 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T88 | 2821-2829 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T89 | 2879-2890 | Disease | denotes | Hypokalemia | http://purl.obolibrary.org/obo/MONDO_0003019 |
T90 | 3073-3081 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T91 | 3301-3310 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T92 | 3393-3401 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T93 | 3447-3455 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T94 | 3464-3487 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T95 | 3492-3504 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T96 | 3550-3558 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T97 | 3563-3575 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T98 | 3663-3686 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T99 | 3746-3754 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T100 | 3763-3786 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T101 | 3791-3803 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T102 | 4122-4130 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T103 | 4279-4291 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T104 | 4293-4301 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T105 | 4781-4789 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T106 | 4811-4835 | Disease | denotes | congestive heart failure | http://purl.obolibrary.org/obo/MONDO_0005009 |
T107 | 4822-4835 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T108 | 5203-5211 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T109 | 5237-5243 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T110 | 5261-5267 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T111 | 5318-5326 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T112 | 5409-5415 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T113 | 5726-5732 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T114 | 5947-5953 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T115 | 6168-6174 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T116 | 6262-6270 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T117 | 6602-6608 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T118 | 6656-6664 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T119 | 6779-6785 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T120 | 6793-6810 | Disease | denotes | viral myocarditis | http://purl.obolibrary.org/obo/MONDO_0023161 |
T121 | 6799-6810 | Disease | denotes | myocarditis | http://purl.obolibrary.org/obo/MONDO_0004496 |
T122 | 6837-6849 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T123 | 6984-6988 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T124 | 7008-7012 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T125 | 7169-7175 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T126 | 7230-7272 | Disease | denotes | ST-segment elevation myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0041656 |
T127 | 7251-7272 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T128 | 7276-7284 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T129 | 7507-7520 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T130 | 7524-7532 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T131 | 7547-7560 | Disease | denotes | Heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T132 | 7727-7738 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T133 | 7761-7769 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T134 | 7849-7857 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T135 | 7886-7896 | Disease | denotes | arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T136 | 8042-8052 | Disease | denotes | arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T137 | 8113-8121 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T138 | 8331-8335 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T139 | 8347-8355 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T140 | 8398-8406 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T141 | 8469-8473 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T142 | 8710-8738 | Disease | denotes | respiratory tract infections | http://purl.obolibrary.org/obo/MONDO_0024355 |
T143 | 8818-8826 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T144 | 9042-9050 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T145 | 9151-9159 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T146 | 9409-9417 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T147 | 9712-9720 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T148 | 9871-9879 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T149 | 10260-10268 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T150 | 10690-10699 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T151 | 11019-11027 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T152 | 11312-11320 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T153 | 11338-11380 | Disease | denotes | ST-segment elevation myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0041656 |
T154 | 11359-11380 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T155 | 11491-11494 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T156 | 11515-11523 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T157 | 11637-11645 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T158 | 11746-11754 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T159 | 11851-11854 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T160 | 12139-12142 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T161 | 12185-12193 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T162 | 12347-12362 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T163 | 12353-12362 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T31 | 18-19 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T32 | 400-405 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T33 | 400-405 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T34 | 400-405 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T35 | 400-405 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T36 | 559-560 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T37 | 660-665 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T38 | 894-903 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T39 | 1083-1094 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
T40 | 1149-1150 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T41 | 1151-1159 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T42 | 1210-1215 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T43 | 1210-1215 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T44 | 1210-1215 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T45 | 1210-1215 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T46 | 1220-1225 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T47 | 1286-1295 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T48 | 1422-1431 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T49 | 1474-1478 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T50 | 1474-1478 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T51 | 1667-1673 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organs |
T52 | 2218-2223 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T53 | 2218-2223 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T54 | 2555-2564 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T55 | 3312-3313 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T56 | 3824-3827 | http://purl.obolibrary.org/obo/CLO_0001562 | denotes | a 2 |
T57 | 3824-3827 | http://purl.obolibrary.org/obo/CLO_0001563 | denotes | a 2 |
T58 | 3986-3987 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T59 | 4607-4612 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2]. A |
T60 | 4700-4701 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T61 | 4822-4827 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T62 | 4822-4827 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T63 | 4822-4827 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T64 | 4822-4827 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T65 | 5733-5736 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T66 | 6018-6019 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T67 | 6175-6178 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T68 | 6209-6210 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T69 | 6447-6450 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T70 | 6714-6717 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T71 | 6927-6928 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T72 | 7023-7025 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T73 | 7086-7088 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T74 | 7107-7112 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T75 | 7113-7118 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T76 | 7113-7118 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T77 | 7113-7118 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T78 | 7113-7118 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T79 | 7183-7188 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T80 | 7199-7202 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T81 | 7230-7232 | http://purl.obolibrary.org/obo/CLO_0009141 | denotes | ST |
T82 | 7230-7232 | http://purl.obolibrary.org/obo/CLO_0050980 | denotes | ST |
T83 | 7507-7512 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T84 | 7507-7512 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T85 | 7507-7512 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T86 | 7507-7512 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T87 | 7547-7552 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | Heart |
T88 | 7547-7552 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | Heart |
T89 | 7547-7552 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | Heart |
T90 | 7547-7552 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | Heart |
T91 | 7577-7579 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
T92 | 7771-7772 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T93 | 8122-8125 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T94 | 8139-8140 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T95 | 9180-9181 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T96 | 9506-9516 | http://purl.obolibrary.org/obo/CLO_0002807 | denotes | in donning |
T97 | 10394-10399 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T98 | 10736-10739 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T99 | 10849-10857 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
T100 | 11070-11073 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T101 | 11086-11087 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T102 | 11338-11340 | http://purl.obolibrary.org/obo/CLO_0009141 | denotes | ST |
T103 | 11338-11340 | http://purl.obolibrary.org/obo/CLO_0050980 | denotes | ST |
T104 | 11391-11394 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T105 | 11400-11401 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T106 | 11610-11624 | http://purl.obolibrary.org/obo/CL_0000746 | denotes | cardiomyocytes |
T107 | 11681-11692 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
T108 | 11703-11704 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 581-585 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
T6 | 622-626 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
T7 | 1109-1120 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T8 | 2021-2027 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
T9 | 2434-2449 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
T10 | 2434-2443 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T11 | 2444-2449 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 2451-2466 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T13 | 2843-2854 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T14 | 2855-2866 | Chemical | denotes | aldosterone | http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834 |
T16 | 7053-7069 | Chemical | denotes | ribonucleic acid | http://purl.obolibrary.org/obo/CHEBI_33697 |
T17 | 7065-7069 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T18 | 7230-7232 | Chemical | denotes | ST | http://purl.obolibrary.org/obo/CHEBI_141393 |
T19 | 8514-8519 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T20 | 8603-8610 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T22 | 10849-10857 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
T23 | 11338-11340 | Chemical | denotes | ST | http://purl.obolibrary.org/obo/CHEBI_141393 |
T24 | 11434-11448 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
T25 | 11438-11448 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T26 | 11450-11454 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T27 | 11460-11471 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T28 | 11846-11850 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T29 | 12134-12138 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T30 | 12402-12407 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T31 | 12451-12456 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T32 | 12541-12552 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T33 | 12553-12571 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T34 | 12576-12588 | Chemical | denotes | azathioprine | http://purl.obolibrary.org/obo/CHEBI_2948 |
T35 | 12689-12694 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T36 | 12847-12858 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T37 | 12859-12877 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T38 | 13032-13036 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T17 | 346-356 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T18 | 360-381 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T19 | 400-413 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T20 | 1612-1626 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
T21 | 1955-1962 | Phenotype | denotes | hypoxia | http://purl.obolibrary.org/obo/HP_0012418 |
T22 | 1979-1998 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
T23 | 2279-2300 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T24 | 2676-2687 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T25 | 2774-2785 | Phenotype | denotes | hypokalemia | http://purl.obolibrary.org/obo/HP_0002900 |
T26 | 2879-2890 | Phenotype | denotes | Hypokalemia | http://purl.obolibrary.org/obo/HP_0002900 |
T27 | 3492-3504 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T28 | 3563-3575 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T29 | 3791-3803 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T30 | 4279-4291 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T31 | 4811-4835 | Phenotype | denotes | congestive heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T32 | 6799-6810 | Phenotype | denotes | myocarditis | http://purl.obolibrary.org/obo/HP_0012819 |
T33 | 7230-7250 | Phenotype | denotes | ST-segment elevation | http://purl.obolibrary.org/obo/HP_0012251 |
T34 | 7251-7272 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T35 | 7340-7377 | Phenotype | denotes | left ventricular systolic dysfunction | http://purl.obolibrary.org/obo/HP_0025169 |
T36 | 7385-7409 | Phenotype | denotes | left ventricular failure | http://purl.obolibrary.org/obo/HP_0005162 |
T37 | 7414-7431 | Phenotype | denotes | cardiogenic shock | http://purl.obolibrary.org/obo/HP_0030149 |
T38 | 7507-7520 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T39 | 7547-7560 | Phenotype | denotes | Heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T40 | 7693-7704 | Phenotype | denotes | Arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T41 | 7727-7738 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T42 | 7886-7896 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T43 | 8042-8052 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T44 | 8710-8738 | Phenotype | denotes | respiratory tract infections | http://purl.obolibrary.org/obo/HP_0011947 |
T45 | 11338-11358 | Phenotype | denotes | ST-segment elevation | http://purl.obolibrary.org/obo/HP_0012251 |
T46 | 11359-11380 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T47 | 12708-12727 | Phenotype | denotes | prolong QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
T48 | 13055-13074 | Phenotype | denotes | prolong QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 1272-1282 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
T11 | 1422-1440 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathways |
T12 | 1422-1431 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T13 | 1506-1518 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T14 | 1586-1607 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
T15 | 2145-2157 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T16 | 2343-2355 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T17 | 6837-6849 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T18 | 8514-8530 | http://purl.obolibrary.org/obo/GO_0006629 | denotes | lipid metabolism |
T19 | 8520-8530 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T20 | 8603-8621 | http://purl.obolibrary.org/obo/GO_0006006 | denotes | glucose metabolism |
T21 | 8611-8621 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T22 | 11282-11294 | http://purl.obolibrary.org/obo/GO_0042730 | denotes | fibrinolysis |
T23 | 12347-12362 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T52 | 0-17 | Sentence | denotes | 2 Search methods |
T53 | 18-243 | Sentence | denotes | A literature search was done using PubMed and Google search engines for original and review articles, advisories from professional societies, and expert commentaries published since the onset of the current COVID-19 epidemic. |
T54 | 244-415 | Sentence | denotes | Search terms “COVID-19” and “coronavirus” were used in combination with “cardiac”, “cardiovascular”, “arrhythmia”, “myocardial infarction”, “troponin” and “heart failure”. |
T55 | 416-502 | Sentence | denotes | Relevant cross-references for previous studies about SARS and MERS were also reviewed. |
T56 | 504-534 | Sentence | denotes | 2.1 Pathogenic considerations |
T57 | 535-598 | Sentence | denotes | SARS-CoV-2 is caused by a novel enveloped RNA beta-coronavirus. |
T58 | 599-828 | Sentence | denotes | Seven species of these beta-coronaviruses are known to cause human infections, with four mainly causing mild flulike symptoms and the remaining three resulting in potentially fatal illnesses (SARS, MERS and the ongoing COVID-19). |
T59 | 829-947 | Sentence | denotes | Although respiratory tract is the primary target for SARS-CoV-2, CV system may get involved in several different ways. |
T60 | 948-1037 | Sentence | denotes | Following are the common mechanisms responsible for CV complications in COVID-19 [3,4]-1. |
T61 | 1039-1226 | Sentence | denotes | Direct myocardial injury- SARS-CoV-2 enters human cells by binding to angiotensin-converting enzyme 2 (ACE2), a membrane bound aminopeptidase which is highly expressed in heart and lungs. |
T62 | 1227-1354 | Sentence | denotes | ACE2 plays an important role in neurohumoral regulation of CV system in normal health as well as in various disease conditions. |
T63 | 1355-1492 | Sentence | denotes | The binding of SARS-CoV-2 to ACE2 can result in alteration of ACE2 signaling pathways, leading to acute myocardial and lung injury [3,4]. |
T64 | 1493-1495 | Sentence | denotes | 2. |
T65 | 1497-1704 | Sentence | denotes | Systemic inflammation- More severe forms of COVID-19 are characterized by acute systemic inflammatory response and cytokine storm, which can result in injury to multiple organs leading to multiorgan failure. |
T66 | 1705-1825 | Sentence | denotes | Studies have shown high circulatory levels of proinflammatory cytokines in patients with severe/critical COVID-19 [5,6]. |
T67 | 1826-1828 | Sentence | denotes | 3. |
T68 | 1830-2091 | Sentence | denotes | Altered myocardial demand-supply ratio- Increased cardiometabolic demand associated with the systemic infection coupled with hypoxia caused by acute respiratory illness can impair myocardial oxygen demand-supply relationship and lead to acute myocardial injury. |
T69 | 2092-2094 | Sentence | denotes | 4. |
T70 | 2096-2301 | Sentence | denotes | Plaque rupture and coronary thrombosis- Systemic inflammation as well as increased shear stress due to increased coronary blood flow can precipitate plaque rupture resulting in acute myocardial infarction. |
T71 | 2302-2383 | Sentence | denotes | Prothrombotic milieu created by systemic inflammation further increases the risk. |
T72 | 2384-2386 | Sentence | denotes | 5. |
T73 | 2388-2565 | Sentence | denotes | Adverse effects of various therapies- Various antiviral drugs, corticosteroids and other therapies aimed at treating COVID-19 can also have deleterious effects on the CV system. |
T74 | 2566-2568 | Sentence | denotes | 6. |
T75 | 2570-2739 | Sentence | denotes | Electrolyte imbalances- Electrolyte imbalances can occur in any critical systemic illness and precipitate arrhythmias, esp. in patients with underlying cardiac disorder. |
T76 | 2740-2878 | Sentence | denotes | There is particular concern about hypokalemia in COVID-19, due to interaction of SARS-CoV-2 with renin-angiotensin-aldosterone system [7]. |
T77 | 2879-2943 | Sentence | denotes | Hypokalemia increases vulnerability to various tachyarrhythmias. |
T78 | 2945-2986 | Sentence | denotes | 2.1.1 Role of underling CV comorbidities |
T79 | 2987-3158 | Sentence | denotes | The patients with pre-existing CVD appear to have heightened vulnerability to develop COVID-19 and tend to have more severe disease with worse clinical outcomes [1,4,6,8]. |
T80 | 3159-3311 | Sentence | denotes | Various CV risk factors also adversely affect porgnosis of these patients, although they do not seem to increase likleihood of developing the infection. |
T81 | 3312-3522 | Sentence | denotes | A meta-analysis of six published studies from China including 1527 patients with COVID-19 reported 9.7%, 16.4% and 17.1% prevalence of diabetes, cardio-cerebrovascular disease and hypertension respectively [4]. |
T82 | 3523-3711 | Sentence | denotes | Although the prevalence of diabetes and hypertension in this cohort was same as in the Chinese general population, the prevalence of cardio-cerebrovascular disease was considerably higher. |
T83 | 3712-3985 | Sentence | denotes | More importantly, the presence of diabetes, cardio-cerebrovascular disease and hypertension was associated with a 2-fold, 3-fold and 2-fold greater risk of severe disease or requiring intensive care unit (ICU) admission, suggesting prognostic impact of these comorbidities. |
T84 | 3986-4135 | Sentence | denotes | A much larger report from the Chinese Center for Disease Control and Prevention described clinical outcomes in 44672 confirmed cases of COVID-19 [1]. |
T85 | 4136-4310 | Sentence | denotes | The overall case fatality rate (CFR) was 2.3% in the entire cohort but significantly higher (6%, 7.3% and 10.5% respectively) in patients with hypertension, diabetes and CVD. |
T86 | 4311-4482 | Sentence | denotes | Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. |
T87 | 4483-4610 | Sentence | denotes | The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. |
T88 | 4611-4733 | Sentence | denotes | A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. |
T89 | 4734-4845 | Sentence | denotes | Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. |
T90 | 4846-4923 | Sentence | denotes | Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. |
T91 | 4924-5163 | Sentence | denotes | However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome. |
T92 | 5165-5211 | Sentence | denotes | 2.2 Cardiovascular manifestations of COVID-19 |
T93 | 5213-5243 | Sentence | denotes | 2.2.1 Acute myocardial injury |
T94 | 5244-5337 | Sentence | denotes | Acute myocardial injury is the most commonly described CV complication in COVID-19 (Table 1). |
T95 | 5338-5529 | Sentence | denotes | Different reports have used different definitions for acute myocardial injury, including rise in cardiac enzymes (different biomarkers and cut-offs) and/or electrocardiographic abnormalities. |
T96 | 5530-5686 | Sentence | denotes | However, an elevation of high-sensitivity cardiac troponin I (cTnI) above 99th percentile upper reference limit is the most commonly used definition.Table 1 |
T97 | 5687-5847 | Sentence | denotes | The overall incidence of acute cardiac injury has been variable but roughly 8–12% of the positive cases are known to develop significant elevation of cTnI [10]. |
T98 | 5848-6117 | Sentence | denotes | The aforementioned meta-analysis of the Chinese studies [4] reported 8% incidence of acute cardiac injury whereas another study including only those patients who had had a definite outcome (death or discharge from hospital) reported 17% incidence of cTnI elevation [5]. |
T99 | 6118-6279 | Sentence | denotes | Regardless of the actual incidence, acute cardiac injury has been consistently shown to be a strong negative prognostic marker in patients with COVID-19 [5,6,8]. |
T100 | 6280-6398 | Sentence | denotes | The patients admitted to ICU or having severe/fatal illness have several-fold higher likelihood of troponin elevation. |
T101 | 6399-6537 | Sentence | denotes | In contrast, the incidence of elevated troponin has been very low (only 1–2%) in patients having mild illness not requiring ICU admission. |
T102 | 6538-6665 | Sentence | denotes | Any of the mechanisms described above can lead to acute cardiac injury and rise in cardiac troponins in patients with COVID-19. |
T103 | 6666-6890 | Sentence | denotes | The relative role of these different mechanisms has not been described but direct (i.e. non-coronary) myocardial injury due to viral myocarditis or the effect of systemic inflammation appear to be the most common mechanisms. |
T104 | 6891-7027 | Sentence | denotes | These observations are supported by a previous autopsy study in patients who had died due to SARS during the Toronto SARS outbreak [11]. |
T105 | 7028-7189 | Sentence | denotes | In this study, the viral ribonucleic acid was detected in 35% of the autopsied human heart samples, providing evidence for direct myocardial injury by the virus. |
T106 | 7190-7311 | Sentence | denotes | No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. |
T107 | 7312-7461 | Sentence | denotes | Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. |
T108 | 7462-7546 | Sentence | denotes | Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. |
T109 | 7547-7684 | Sentence | denotes | Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital. |
T110 | 7686-7704 | Sentence | denotes | 2.2.2 Arrhythmias |
T111 | 7705-7770 | Sentence | denotes | Both tachy- and brady-arrhythmias are known to occur in COVID-19. |
T112 | 7771-7901 | Sentence | denotes | A study describing clinical profile and outcomes in 138 Chinese patients with COVID-19 reported 16.7% incidence of arrhythmia [8]. |
T113 | 7902-8029 | Sentence | denotes | The incidence was much higher (44.4%) in those requiring ICU admission as compared to those not requiring ICU admission (8.9%). |
T114 | 8030-8071 | Sentence | denotes | The type of arrhythmia was not described. |
T115 | 8073-8112 | Sentence | denotes | 2.2.3 Potential long-term consequences |
T116 | 8113-8251 | Sentence | denotes | COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. |
T117 | 8252-8409 | Sentence | denotes | However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. |
T118 | 8410-8634 | Sentence | denotes | It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. |
T119 | 8635-8744 | Sentence | denotes | Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. |
T120 | 8745-8948 | Sentence | denotes | Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD. |
T121 | 8950-8978 | Sentence | denotes | 2.3 Management implications |
T122 | 8979-9160 | Sentence | denotes | The overall management principles for patients presenting with COVID-19 who develop CV complications or who have pre-existing CVD are same as for any other patient without COVID-19. |
T123 | 9161-9229 | Sentence | denotes | However, there are a few important points that need consideration-1. |
T124 | 9230-9350 | Sentence | denotes | As caregivers, it is our utmost responsibility to protect ourselves from getting infected while managing these patients. |
T125 | 9351-9475 | Sentence | denotes | Therefore, all heathcare personnel engaged in the care of COVID-19 patients must observe necessary precautions at all times. |
T126 | 9476-9626 | Sentence | denotes | All of them should be trained in donning, usage, and doffing of the personal protective equipment in accordance with the existing practice guidelines. |
T127 | 9627-9629 | Sentence | denotes | 2. |
T128 | 9630-9790 | Sentence | denotes | The hospital systems need to ensure preparedness for dealing with large volume of COVID-19 patients, many of whom would need ICU care and/or acute cardiac care. |
T129 | 9791-9950 | Sentence | denotes | Appropriate protocols for rapid diagnosis, triage, isolation, and management of COVID-19 patients with CV complications should be developed and well-rehearsed. |
T130 | 9951-10119 | Sentence | denotes | Rapid triaging and management of these patients is crucial, not only to allow efficient utilization of healthcare resources but also to minimize exposure to caregivers. |
T131 | 10120-10274 | Sentence | denotes | There are already reports highlighting delays in delivering acute cardiac care due to extra precautions that need to be observed in view of COVID-19 [14]. |
T132 | 10275-10322 | Sentence | denotes | Efforts should be made to minimize such delays. |
T133 | 10323-10325 | Sentence | denotes | 3. |
T134 | 10326-10466 | Sentence | denotes | Strong emphasis should be placed on avoiding unwarranted diagnostic tests (e.g. cardiac troponin, echocardiography, etc.) in these patients. |
T135 | 10467-10700 | Sentence | denotes | This is required to minimize unwarranted downstream diagnostic/therapeutic procedures which would further strain the already stretched healthcare resources and would also subject caregivers to added risk of exposure to the infection. |
T136 | 10701-10863 | Sentence | denotes | The American College of Cardiology has released an advisory discouraging random measurement of cardiac biomarkers such as troponins and natriuretic peptides [15]. |
T137 | 10864-11028 | Sentence | denotes | It urges all the clinicians to reserve these assays for circumstances in which they would actually meaningfully add to the management of the patients with COVID-19. |
T138 | 11029-11166 | Sentence | denotes | The American Society of Echocardiography has also issued a similar advisory regarding the use of echocardiography in these patients [16]. |
T139 | 11167-11169 | Sentence | denotes | 4. |
T140 | 11170-11381 | Sentence | denotes | The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction. |
T141 | 11382-11384 | Sentence | denotes | 5. |
T142 | 11385-11533 | Sentence | denotes | There has been a concern regarding the safety of ACE inhibitors (ACEi) and angiotensin receptor blockers (ARB) during the ongoing COVID-19 pandemic. |
T143 | 11534-11630 | Sentence | denotes | These agents upregulate expression of ACE2 in various tissues, including on cardiomyocytes [17]. |
T144 | 11631-11855 | Sentence | denotes | Since SARS-CoV-2 binds to ACE2 to gain entry into human cells, there is a potentially increased risk of developing COVID-19 or developing more severe disease in patients who are already on background treatment with ACEi/ARB. |
T145 | 11856-11946 | Sentence | denotes | However, to date, no experimental or clinical data have emerged to support these concerns. |
T146 | 11947-12023 | Sentence | denotes | At the same time, the risks of discontinuing these therapies are well known. |
T147 | 12024-12202 | Sentence | denotes | Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]. |
T148 | 12203-12205 | Sentence | denotes | 6. |
T149 | 12206-12363 | Sentence | denotes | Clinicians caring for these patients also need to be fully aware of the potential CV side-effects of various therapies used for treating the viral infection. |
T150 | 12364-12525 | Sentence | denotes | Additionally, various anti-retroviral drugs have significant interactions with cardiac drugs, which need to be considered and appropriate dose modification done. |
T151 | 12526-12677 | Sentence | denotes | More recently, chloroquine/hydroxychloroquine and azathioprine have been proposed as potential therapeutic options, based on preliminary evidence [20]. |
T152 | 12678-12792 | Sentence | denotes | Both these drugs are known to prolong QT interval and due caution must be exercised when prescribing these agents. |
T153 | 12793-13075 | Sentence | denotes | Their combination is best avoided and even when using chloroquine/hydroxychloroquine alone, daily electrocardiogram for monitoring QT interval is warranted, esp. in patients with hepatic or renal dysfunction and in those receiving another drug with potential to prolong QT interval. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T102 | 225-233 | SP_7 | denotes | COVID-19 |
T103 | 258-266 | SP_7 | denotes | COVID-19 |
T104 | 273-284 | NCBITaxon:11118 | denotes | coronavirus |
T105 | 317-324 | UBERON:0000948 | denotes | cardiac |
T106 | 328-342 | UBERON:0004535 | denotes | cardiovascular |
T107 | 360-370 | UBERON:0002349 | denotes | myocardial |
T108 | 400-405 | UBERON:0000948 | denotes | heart |
T109 | 469-473 | SP_10 | denotes | SARS |
T110 | 478-482 | SP_9 | denotes | MERS |
T111 | 535-545 | SP_7 | denotes | SARS-CoV-2 |
T112 | 586-597 | NCBITaxon:11118 | denotes | coronavirus |
T113 | 605-612 | NCBITaxon:species | denotes | species |
T114 | 627-640 | NCBITaxon:11118 | denotes | coronaviruses |
T115 | 660-665 | SP_6;NCBITaxon:9606 | denotes | human |
T116 | 791-795 | SP_10 | denotes | SARS |
T117 | 797-801 | SP_9 | denotes | MERS |
T118 | 818-826 | SP_7 | denotes | COVID-19 |
T119 | 838-855 | UBERON:0000065 | denotes | respiratory tract |
T120 | 882-892 | SP_7 | denotes | SARS-CoV-2 |
T121 | 1020-1028 | SP_7 | denotes | COVID-19 |
T122 | 1046-1056 | UBERON:0002349 | denotes | myocardial |
T123 | 1065-1075 | SP_7 | denotes | SARS-CoV-2 |
T124 | 1083-1088 | SP_6;NCBITaxon:9606 | denotes | human |
T125 | 1109-1140 | PG_10;PR:000003622 | denotes | angiotensin-converting enzyme 2 |
T126 | 1142-1146 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T127 | 1151-1159 | GO:0016020 | denotes | membrane |
T128 | 1197-1206 | GO:0010467 | denotes | expressed |
T129 | 1210-1215 | UBERON:0000948 | denotes | heart |
T130 | 1220-1225 | UBERON:0000170 | denotes | lungs |
T131 | 1227-1231 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T132 | 1272-1282 | GO:0065007 | denotes | regulation |
T133 | 1286-1288 | UBERON:0001017 | denotes | CV |
T134 | 1370-1380 | SP_7 | denotes | SARS-CoV-2 |
T135 | 1384-1388 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T136 | 1417-1421 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T137 | 1459-1469 | UBERON:0002349 | denotes | myocardial |
T138 | 1474-1478 | UBERON:0002048 | denotes | lung |
T177 | 1541-1549 | SP_7 | denotes | COVID-19 |
T178 | 1667-1673 | UBERON:0000062 | denotes | organs |
T179 | 1685-1695 | UBERON:0000062 | denotes | multiorgan |
T180 | 1810-1818 | SP_7 | denotes | COVID-19 |
T181 | 1838-1848 | UBERON:0002349 | denotes | myocardial |
T182 | 1979-1990 | UBERON:0001004 | denotes | respiratory |
T183 | 2010-2020 | UBERON:0002349 | denotes | myocardial |
T184 | 2073-2083 | UBERON:0002349 | denotes | myocardial |
T185 | 2115-2123 | UBERON:0005985 | denotes | coronary |
T186 | 2124-2134 | GO:0007596 | denotes | thrombosis |
T187 | 2209-2217 | UBERON:0005985 | denotes | coronary |
T188 | 2218-2223 | UBERON:0000178 | denotes | blood |
T189 | 2279-2289 | UBERON:0002349 | denotes | myocardial |
T190 | 2302-2315 | GO:0007596 | denotes | Prothrombotic |
T191 | 2444-2449 | CHEBI:36044;CHEBI:36044 | denotes | drugs |
T192 | 2451-2466 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T193 | 2505-2513 | SP_7 | denotes | COVID-19 |
T194 | 2722-2729 | UBERON:0000948 | denotes | cardiac |
T195 | 2789-2797 | SP_7 | denotes | COVID-19 |
T196 | 2821-2831 | SP_7 | denotes | SARS-CoV-2 |
T197 | 2837-2842 | PR:000013883 | denotes | renin |
T198 | 3073-3081 | SP_7 | denotes | COVID-19 |
T199 | 3393-3401 | SP_7 | denotes | COVID-19 |
T200 | 3464-3479 | UBERON:0002037 | denotes | cerebrovascular |
T201 | 3663-3678 | UBERON:0002037 | denotes | cerebrovascular |
T202 | 3763-3778 | UBERON:0002037 | denotes | cerebrovascular |
T203 | 3906-3910 | CL:0000037 | denotes | care |
T204 | 4122-4130 | SP_7 | denotes | COVID-19 |
T205 | 4822-4827 | UBERON:0000948 | denotes | heart |
T206 | 4852-4859 | UBERON:0000948 | denotes | cardiac |
T207 | 4918-4922 | GO:0016265 | denotes | died |
T208 | 4998-5004 | GO:0016265 | denotes | deaths |
T209 | 5170-5184 | UBERON:0004535 | denotes | Cardiovascular |
T210 | 5203-5211 | SP_7 | denotes | COVID-19 |
T211 | 5226-5236 | UBERON:0002349 | denotes | myocardial |
T212 | 5250-5260 | UBERON:0002349 | denotes | myocardial |
T213 | 5318-5326 | SP_7 | denotes | COVID-19 |
T214 | 5398-5408 | UBERON:0002349 | denotes | myocardial |
T215 | 5435-5442 | UBERON:0000948 | denotes | cardiac |
T216 | 5572-5579 | UBERON:0000948 | denotes | cardiac |
T217 | 5718-5725 | UBERON:0000948 | denotes | cardiac |
T218 | 5939-5946 | UBERON:0000948 | denotes | cardiac |
T219 | 6038-6043 | GO:0016265 | denotes | death |
T220 | 6160-6167 | UBERON:0000948 | denotes | cardiac |
T221 | 6262-6270 | SP_7 | denotes | COVID-19 |
T222 | 6594-6601 | UBERON:0000948 | denotes | cardiac |
T223 | 6621-6628 | UBERON:0000948 | denotes | cardiac |
T224 | 6656-6664 | SP_7 | denotes | COVID-19 |
T225 | 6758-6766 | UBERON:0001621 | denotes | coronary |
T226 | 6768-6778 | UBERON:0002349 | denotes | myocardial |
T227 | 6793-6798 | NCBITaxon:10239 | denotes | viral |
T228 | 6972-6976 | GO:0016265 | denotes | died |
T229 | 6984-6988 | SP_10 | denotes | SARS |
T230 | 7008-7012 | SP_10 | denotes | SARS |
T231 | 7047-7052 | NCBITaxon:10239 | denotes | viral |
T232 | 7107-7112 | SP_6;NCBITaxon:9606 | denotes | human |
T233 | 7113-7118 | UBERON:0000948 | denotes | heart |
T234 | 7158-7168 | UBERON:0002349 | denotes | myocardial |
T235 | 7183-7188 | NCBITaxon:10239 | denotes | virus |
T236 | 7251-7261 | UBERON:0002349 | denotes | myocardial |
T237 | 7276-7284 | SP_7 | denotes | COVID-19 |
T238 | 7340-7356 | UBERON:0002084 | denotes | left ventricular |
T239 | 7385-7401 | UBERON:0002084 | denotes | left ventricular |
T240 | 7507-7512 | UBERON:0000948 | denotes | heart |
T241 | 7524-7532 | SP_7 | denotes | COVID-19 |
T242 | 7547-7552 | UBERON:0000948 | denotes | Heart |
T243 | 7614-7618 | GO:0016265 | denotes | died |
T244 | 7761-7769 | SP_7 | denotes | COVID-19 |
T245 | 7849-7857 | SP_7 | denotes | COVID-19 |
T246 | 8113-8121 | SP_7 | denotes | COVID-19 |
T247 | 8276-8284 | CHEBI:33695;CHEBI:33695;SO:0000673 | denotes | messages |
T248 | 8331-8335 | SP_10 | denotes | SARS |
T249 | 8347-8355 | SP_10 | denotes | SARS-CoV |
T250 | 8398-8408 | SP_7 | denotes | SARS-CoV-2 |
T251 | 8469-8473 | SP_10 | denotes | SARS |
T252 | 8514-8519 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
T253 | 8520-8530 | GO:0006629 | denotes | metabolism |
T254 | 8603-8610 | CHEBI:17234;CHEBI:17234;GO:0006006 | denotes | glucose |
T255 | 8611-8621 | GO:0006006 | denotes | metabolism |
T256 | 8710-8727 | UBERON:0000065 | denotes | respiratory tract |
T257 | 8818-8826 | SP_7 | denotes | COVID-19 |
T258 | 9042-9050 | SP_7 | denotes | COVID-19 |
T259 | 9151-9159 | SP_7 | denotes | COVID-19 |
T260 | 9409-9417 | SP_7 | denotes | COVID-19 |
T261 | 9712-9720 | SP_7 | denotes | COVID-19 |
T262 | 9777-9784 | UBERON:0000948 | denotes | cardiac |
T263 | 9871-9879 | SP_7 | denotes | COVID-19 |
T264 | 10169-10179 | GO:0007567 | denotes | delivering |
T265 | 10186-10193 | UBERON:0000948 | denotes | cardiac |
T266 | 10260-10268 | SP_7 | denotes | COVID-19 |
T267 | 10406-10413 | UBERON:0000948 | denotes | cardiac |
T268 | 10725-10735 | UBERON:0000948 | denotes | Cardiology |
T269 | 10796-10803 | UBERON:0000948 | denotes | cardiac |
T270 | 11019-11027 | SP_7 | denotes | COVID-19 |
T271 | 11282-11294 | GO:0042730 | denotes | fibrinolysis |
T272 | 11312-11320 | SP_7 | denotes | COVID-19 |
T273 | 11359-11369 | UBERON:0002349 | denotes | myocardial |
T274 | 11438-11448 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T275 | 11472-11489 | CHEBI:48561;CHEBI:48561 | denotes | receptor blockers |
T276 | 11515-11523 | SP_7 | denotes | COVID-19 |
T277 | 11558-11568 | GO:0010467 | denotes | expression |
T278 | 11572-11576 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T279 | 11588-11595 | UBERON:0000479 | denotes | tissues |
T280 | 11610-11624 | CL:0000746 | denotes | cardiomyocytes |
T281 | 11637-11647 | SP_7 | denotes | SARS-CoV-2 |
T282 | 11657-11661 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T283 | 11681-11686 | SP_6;NCBITaxon:9606 | denotes | human |
T284 | 11746-11754 | SP_7 | denotes | COVID-19 |
T285 | 12185-12193 | SP_7 | denotes | COVID-19 |
T286 | 12347-12352 | NCBITaxon:10239 | denotes | viral |
T287 | 12386-12391 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
T288 | 12391-12401 | NCBITaxon:11632 | denotes | retroviral |
T289 | 12402-12407 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T290 | 12443-12450 | UBERON:0000948 | denotes | cardiac |
T291 | 12451-12456 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T292 | 12541-12552 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T293 | 12553-12571 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T294 | 12576-12588 | CHEBI:2948;CHEBI:2948 | denotes | azathioprine |
T295 | 12689-12694 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T296 | 12785-12791 | CHEBI:23888;CHEBI:23888 | denotes | agents |
T297 | 12847-12858 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T298 | 12859-12877 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T299 | 12972-12979 | UBERON:0002107 | denotes | hepatic |
T300 | 12983-12988 | UBERON:0002113 | denotes | renal |
T301 | 13032-13036 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T36 | 6594-6601 | UBERON:0000948 | denotes | cardiac |
T27626 | 7158-7168 | UBERON:0002349 | denotes | myocardial |
T52612 | 7345-7356 | UBERON:0002082 | denotes | ventricular |
T27094 | 7385-7401 | UBERON:0002084 | denotes | left ventricular |
T90623 | 2037-2045 | SP_7 | denotes | pply rel |
T3419 | 2091-2099 | UBERON:0000948 | denotes | 4. Pla |
T78722 | 2347-2355 | SP_7 | denotes | ammation |
T53635 | 2360-2369 | GO:0007612 | denotes | her incre |
T94419 | 2389-2400 | NCBITaxon:11118 | denotes | dverse effe |
T38989 | 2419-2424 | SP_10 | denotes | apies |
T67414 | 2462-2466 | SP_9 | denotes | oids |
T60021 | 2696-2704 | SP_7 | denotes | patient |
T3699 | 2728-2736 | SP_7 | denotes | c disord |
T86101 | 2743-2754 | NCBITaxon:11118 | denotes | re is parti |
T88588 | 2787-2794 | UBERON:0000948 | denotes | n COVID |
T53986 | 2798-2812 | UBERON:0004535 | denotes | due to intera |
T35855 | 2830-2840 | UBERON:0002349 | denotes | 2 with ren |
T55568 | 2870-2875 | UBERON:0000948 | denotes | tem [ |
T45400 | 2939-2943 | SP_10 | denotes | ias. |
T96699 | 2949-2954 | SP_9 | denotes | 1 Ro |
T94696 | 3005-3016 | SP_7 | denotes | pre-existin |
T73378 | 3054-3065 | NCBITaxon:11118 | denotes | ability to |
T49479 | 3073-3080 | NCBITaxon:species | denotes | COVID-1 |
T49662 | 3092-3105 | NCBITaxon:11118 | denotes | o have more s |
T91764 | 3125-3130 | SP_6;NCBITaxon:9606 | denotes | orse |
T16144 | 3256-3260 | SP_10 | denotes | eem |
T61914 | 3262-3266 | SP_9 | denotes | inc |
T67143 | 3283-3291 | SP_7 | denotes | of devel |
T79419 | 3304-3322 | UBERON:0000065 | denotes | ection. A meta-ana |
T22287 | 3349-3361 | SP_7 | denotes | ies from Chi |
T48200 | 3489-3497 | SP_7 | denotes | nd hyper |
T78437 | 3514-3524 | UBERON:0002349 | denotes | ely [4]. A |
T61571 | 3533-3543 | SP_7 | denotes | he prevale |
T36103 | 3551-3556 | SP_6;NCBITaxon:9606 | denotes | iabet |
T42181 | 3577-3608 | PG_10;PR:000003622 | denotes | n this cohort was same as in th |
T13911 | 3610-3616 | G_3;PG_10;PR:000003622 | denotes | Chines |
T79903 | 3621-3629 | GO:0016020 | denotes | eral pop |
T50101 | 3667-3676 | GO:0010467 | denotes | brovascul |
T80107 | 3680-3685 | UBERON:0000948 | denotes | iseas |
T55772 | 3690-3695 | UBERON:0000170 | denotes | cons |
T53520 | 3697-3701 | G_3;PG_10;PR:000003622 | denotes | erab |
T48624 | 3742-3752 | GO:0065007 | denotes | of diabet |
T21124 | 3756-3758 | UBERON:0001017 | denotes | ca |
T78086 | 3840-3850 | SP_7 | denotes | and 2-fol |
T54232 | 3854-3858 | G_3;PG_10;PR:000003622 | denotes | eate |
T64983 | 3887-3891 | G_3;PG_10;PR:000003622 | denotes | equi |
T4317 | 3929-3939 | UBERON:0002349 | denotes | on, sugges |
T54741 | 3944-3948 | UBERON:0002048 | denotes | prog |
T139 | 4010-4020 | SP_7 | denotes | m the Chin |
T140 | 4137-4143 | UBERON:0000062 | denotes | he ove |
T141 | 4155-4164 | UBERON:0000062 | denotes | tality ra |
T142 | 4279-4287 | SP_7 | denotes | hyperten |
T143 | 4305-4315 | UBERON:0002349 | denotes | CVD. Alth |
T144 | 4443-4453 | UBERON:0001004 | denotes | across di |
T145 | 4475-4485 | UBERON:0002349 | denotes | ations. Th |
T146 | 4540-4550 | UBERON:0002349 | denotes | and many o |
T147 | 4581-4589 | UBERON:0005985 | denotes | in some |
T148 | 4590-4600 | GO:0007596 | denotes | uropean na |
T149 | 4675-4683 | UBERON:0005985 | denotes | tes of A |
T150 | 4684-4689 | UBERON:0000178 | denotes | erica |
T151 | 4744-4754 | UBERON:0002349 | denotes | ies were c |
T152 | 4767-4780 | GO:0007596 | denotes | cohort, with |
T153 | 4906-4911 | CHEBI:36044;CHEBI:36044 | denotes | 4% pa |
T154 | 4913-4928 | CHEBI:50858;CHEBI:50858 | denotes | ents died. Howe |
T155 | 4966-4974 | SP_7 | denotes | tes seem |
T156 | 5184-5191 | UBERON:0000948 | denotes | manife |
T157 | 5253-5261 | SP_7 | denotes | cardial |
T158 | 5285-5295 | SP_7 | denotes | nly descri |
T159 | 5301-5306 | PR:000013883 | denotes | comp |
T160 | 5418-5428 | UBERON:0002349 | denotes | ncluding r |
T161 | 5437-5447 | SP_7 | denotes | rdiac enzy |
T162 | 5455-5460 | SP_6;NCBITaxon:9606 | denotes | feren |
T163 | 5481-5514 | PG_10;PR:000003622 | denotes | offs) and/or electrocardiographic |
T164 | 5516-5520 | G_3;PG_10;PR:000003622 | denotes | bnor |
T165 | 5525-5533 | GO:0016020 | denotes | ies. How |
T166 | 5571-5580 | GO:0010467 | denotes | cardiac |
T167 | 5584-5589 | UBERON:0000948 | denotes | onin |
T168 | 5594-5599 | UBERON:0000170 | denotes | nI) a |
T169 | 5601-5605 | G_3;PG_10;PR:000003622 | denotes | ve 9 |
T170 | 5646-5656 | GO:0065007 | denotes | he most co |
T171 | 5660-5662 | UBERON:0001017 | denotes | ly |
T172 | 5744-5754 | SP_7 | denotes | riable but |
T173 | 5758-5762 | G_3;PG_10;PR:000003622 | denotes | ghly |
T174 | 5791-5795 | G_3;PG_10;PR:000003622 | denotes | are |
T175 | 5833-5843 | UBERON:0002349 | denotes | of cTnI [ |
T176 | 5848-5852 | UBERON:0002048 | denotes | The |
T64923 | 5918-5926 | SP_7 | denotes | % incide |
T13398 | 6043-6049 | UBERON:0000062 | denotes | or di |
T97031 | 6061-6071 | UBERON:0000062 | denotes | hospital) |
T12823 | 6186-6194 | SP_7 | denotes | nsistent |
T99017 | 6213-6223 | UBERON:0002349 | denotes | rong negat |
T3576 | 6351-6361 | UBERON:0001004 | denotes | l-fold hig |
T98428 | 6381-6391 | UBERON:0002349 | denotes | oponin ele |
T52387 | 6444-6454 | UBERON:0002349 | denotes | in has bee |
T17293 | 6485-6493 | UBERON:0005985 | denotes | nts havi |
T14874 | 6494-6504 | GO:0007596 | denotes | g mild ill |
T22127 | 6579-6587 | UBERON:0005985 | denotes | lead to |
T81653 | 6588-6593 | UBERON:0000178 | denotes | acute |
T33438 | 6648-6658 | UBERON:0002349 | denotes | ts with CO |
T74631 | 6671-6684 | GO:0007596 | denotes | elative role |
T1706 | 6811-6816 | CHEBI:36044;CHEBI:36044 | denotes | or th |
T69753 | 6818-6833 | CHEBI:50858;CHEBI:50858 | denotes | effect of syste |
T40512 | 6871-6879 | SP_7 | denotes | common |
T95131 | 7087-7094 | UBERON:0000948 | denotes | 5% of t |
T55330 | 7156-7164 | SP_7 | denotes | t myocar |
T43403 | 7188-7198 | SP_7 | denotes | . No study |
T97008 | 7204-7209 | PR:000013883 | denotes | escri |
T90587 | 7437-7445 | SP_7 | denotes | also not |
T23923 | 7757-7765 | SP_7 | denotes | in COVI |
T59830 | 7830-7845 | UBERON:0002037 | denotes | nese patients w |
T91364 | 8028-8043 | UBERON:0002037 | denotes | . The type of a |
T92815 | 8130-8145 | UBERON:0002037 | denotes | ged only a few |
T25744 | 8273-8277 | CL:0000037 | denotes | nt m |
T92830 | 8487-8495 | SP_7 | denotes | d to hav |
T44699 | 9191-9196 | UBERON:0000948 | denotes | tant |
T13321 | 9221-9228 | UBERON:0000948 | denotes | ation-1 |
T1958 | 9287-9291 | GO:0016265 | denotes | our |
T10093 | 9366-9372 | GO:0016265 | denotes | heathc |
T26141 | 9536-9550 | UBERON:0004535 | denotes | of the person |
T57516 | 9569-9577 | SP_7 | denotes | ment in |
T16826 | 9590-9601 | UBERON:0002349 | denotes | th the exis |
T31833 | 9615-9625 | UBERON:0002349 | denotes | guidelines |
T58582 | 9684-9692 | SP_7 | denotes | ealing w |
T94661 | 9764-9774 | UBERON:0002349 | denotes | and/or acu |
T87705 | 9801-9808 | UBERON:0000948 | denotes | e proto |
T48656 | 9937-9944 | UBERON:0000948 | denotes | ll-rehe |
T7641 | 10084-10091 | UBERON:0000948 | denotes | to mini |
T19884 | 10301-10308 | UBERON:0000948 | denotes | minimiz |
T28710 | 10400-10405 | GO:0016265 | denotes | (e.g. |
T28698 | 10521-10528 | UBERON:0000948 | denotes | agnosti |
T59720 | 10623-10631 | SP_7 | denotes | and woul |
T39589 | 10955-10962 | UBERON:0000948 | denotes | ctually |
T43336 | 10982-10989 | UBERON:0000948 | denotes | the ma |
T74507 | 11017-11025 | SP_7 | denotes | h COVID- |
T87124 | 11119-11127 | UBERON:0001621 | denotes | use of e |
T70670 | 11129-11139 | UBERON:0002349 | denotes | ocardiogra |
T13529 | 11154-11159 | NCBITaxon:10239 | denotes | tient |
T86273 | 11334-11338 | GO:0016265 | denotes | ith |
T62094 | 11346-11350 | SP_10 | denotes | nt e |
T86471 | 11370-11374 | SP_10 | denotes | infa |
T29868 | 11409-11414 | NCBITaxon:10239 | denotes | rega |
T44693 | 11466-11471 | SP_6;NCBITaxon:9606 | denotes | ensin |
T30153 | 11472-11477 | UBERON:0000948 | denotes | recep |
T84285 | 11517-11527 | UBERON:0002349 | denotes | VID-19 pan |
T53976 | 11542-11547 | NCBITaxon:10239 | denotes | ents |
T87440 | 11610-11620 | UBERON:0002349 | denotes | cardiomyoc |
T16635 | 11635-11643 | SP_7 | denotes | e SARS-C |
T1147 | 11699-11715 | UBERON:0002084 | denotes | is a potentiall |
T55144 | 11745-11761 | UBERON:0002084 | denotes | COVID-19 or dev |
T79081 | 11866-11871 | UBERON:0000948 | denotes | o dat |
T98834 | 11883-11891 | SP_7 | denotes | mental o |
T81730 | 11906-11911 | UBERON:0000948 | denotes | have |
T81536 | 11973-11977 | GO:0016265 | denotes | s of |
T85605 | 12120-12128 | SP_7 | denotes | lly-indi |
T35536 | 12206-12214 | SP_7 | denotes | Clinicia |
T14057 | 12468-12476 | SP_7 | denotes | to be c |
T37740 | 12631-12639 | CHEBI:33695;CHEBI:33695;SO:0000673 | denotes | c option |
T78714 | 12686-12690 | SP_10 | denotes | se d |
T37413 | 12702-12710 | SP_10 | denotes | wn to pr |
T33567 | 12754-12764 | SP_7 | denotes | ercised wh |
T76508 | 12825-12829 | SP_10 | denotes | d an |
T48944 | 12869-12873 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | oroq |
T57411 | 12874-12882 | GO:0006629 | denotes | ine alon |
T94539 | 12955-12962 | CHEBI:17234;CHEBI:17234;GO:0006006 | denotes | in pati |
T59989 | 12963-12971 | GO:0006006 | denotes | nts with |
T36067 | 5555-5563 | SP_7 | denotes | high-sen |
T8537 | 5853-5861 | SP_7 | denotes | forement |
T40400 | 5922-5929 | UBERON:0000948 | denotes | cidence |
T31575 | 6015-6023 | SP_7 | denotes | ad a def |
T82368 | 6313-6323 | GO:0007567 | denotes | aving seve |
T24251 | 6330-6337 | UBERON:0000948 | denotes | l illne |
T24920 | 6404-6412 | SP_7 | denotes | ntrast, |
T47609 | 6548-6555 | UBERON:0000948 | denotes | mechan |
T90774 | 6867-6877 | UBERON:0000948 | denotes | most commo |
T51367 | 6938-6945 | UBERON:0000948 | denotes | autopsy |
T20059 | 7164-7172 | SP_7 | denotes | dial inj |
T82666 | 7424-7436 | GO:0042730 | denotes | c shock have |
T97480 | 7454-7462 | SP_7 | denotes | cribed. |
T23223 | 7503-7513 | UBERON:0002349 | denotes | of heart |
T84766 | 7580-7590 | CHEBI:35222;CHEBI:35222 | denotes | of the pa |
T62908 | 7614-7631 | CHEBI:48561;CHEBI:48561 | denotes | died and in 12% o |
T65791 | 7657-7665 | SP_7 | denotes | scharged |
T61160 | 7703-7713 | GO:0010467 | denotes | s Both tac |
T42698 | 7717-7721 | G_3;PG_10;PR:000003622 | denotes | and |
T8716 | 7733-7740 | UBERON:0000479 | denotes | hmias a |
T34153 | 7755-7769 | CL:0000746 | denotes | ur in COVID-19 |
T6986 | 7782-7792 | SP_7 | denotes | cribing cl |
T91871 | 7802-7806 | G_3;PG_10;PR:000003622 | denotes | file |
T13099 | 7826-7833 | SP_6;NCBITaxon:9606 | denotes | Chines |
T51665 | 7892-7900 | SP_7 | denotes | hmia [8] |
T10783 | 8330-8338 | SP_7 | denotes | SARS, c |
T27416 | 8490-8495 | NCBITaxon:10239 | denotes | o hav |
T34190 | 8532-8537 | CHEBI:67079;CHEBI:67079 | denotes | t 12- |
T90459 | 8537-8547 | NCBITaxon:11632 | denotes | years foll |
T6997 | 8548-8553 | CHEBI:23888;CHEBI:23888 | denotes | w-up; |
T89731 | 8589-8596 | UBERON:0000948 | denotes | % and a |
T12959 | 8597-8602 | CHEBI:23888;CHEBI:23888 | denotes | tered |
T37980 | 8689-8700 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | ecovering f |
T83335 | 8701-8720 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | om other respirator |
T32885 | 8725-8737 | CHEBI:2948;CHEBI:2948 | denotes | ct infection |
T65115 | 8838-8843 | CHEBI:23888;CHEBI:23888 | denotes | porta |
T66265 | 8933-8939 | CHEBI:23888;CHEBI:23888 | denotes | rom fu |
T68492 | 8997-9008 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | ment princi |
T72351 | 9009-9027 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | les for patients p |
T96108 | 9123-9130 | UBERON:0002107 | denotes | r any o |
T69138 | 9134-9139 | UBERON:0002113 | denotes | pati |
T30274 | 9183-9187 | CHEBI:23888;CHEBI:23888 | denotes | ew i |
T302 | 9409-9417 | SP_7 | denotes | COVID-19 |
T303 | 9712-9720 | SP_7 | denotes | COVID-19 |
T304 | 9777-9784 | UBERON:0000948 | denotes | cardiac |
T305 | 9871-9879 | SP_7 | denotes | COVID-19 |
T306 | 10169-10179 | GO:0007567 | denotes | delivering |
T307 | 10186-10193 | UBERON:0000948 | denotes | cardiac |
T308 | 10260-10268 | SP_7 | denotes | COVID-19 |
T309 | 10406-10413 | UBERON:0000948 | denotes | cardiac |
T310 | 10725-10735 | UBERON:0000948 | denotes | Cardiology |
T311 | 10796-10803 | UBERON:0000948 | denotes | cardiac |
T312 | 11019-11027 | SP_7 | denotes | COVID-19 |
T313 | 11282-11294 | GO:0042730 | denotes | fibrinolysis |
T314 | 11312-11320 | SP_7 | denotes | COVID-19 |
T315 | 11359-11369 | UBERON:0002349 | denotes | myocardial |
T316 | 11438-11448 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T317 | 11472-11489 | CHEBI:48561;CHEBI:48561 | denotes | receptor blockers |
T318 | 11515-11523 | SP_7 | denotes | COVID-19 |
T319 | 11558-11568 | GO:0010467 | denotes | expression |
T320 | 11572-11576 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T321 | 11588-11595 | UBERON:0000479 | denotes | tissues |
T322 | 11610-11624 | CL:0000746 | denotes | cardiomyocytes |
T323 | 11637-11647 | SP_7 | denotes | SARS-CoV-2 |
T324 | 11657-11661 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T325 | 11681-11686 | SP_6;NCBITaxon:9606 | denotes | human |
T326 | 11746-11754 | SP_7 | denotes | COVID-19 |
T327 | 12185-12193 | SP_7 | denotes | COVID-19 |
T328 | 12347-12352 | NCBITaxon:10239 | denotes | viral |
T329 | 12386-12391 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
T330 | 12391-12401 | NCBITaxon:11632 | denotes | retroviral |
T331 | 12402-12407 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T332 | 12443-12450 | UBERON:0000948 | denotes | cardiac |
T333 | 12451-12456 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T334 | 12541-12552 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T335 | 12553-12571 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T336 | 12576-12588 | CHEBI:2948;CHEBI:2948 | denotes | azathioprine |
T337 | 12689-12694 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T338 | 12785-12791 | CHEBI:23888;CHEBI:23888 | denotes | agents |
T339 | 12847-12858 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T340 | 12859-12877 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T341 | 12972-12979 | UBERON:0002107 | denotes | hepatic |
T342 | 12983-12988 | UBERON:0002113 | denotes | renal |
T343 | 13032-13036 | CHEBI:23888;CHEBI:23888 | denotes | drug |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32247212-31986264-25241178 | 1822-1823 | 31986264 | denotes | 6 |
32247212-31986264-25241179 | 3153-3154 | 31986264 | denotes | 6 |
32247212-31986264-25241180 | 6274-6275 | 31986264 | denotes | 6 |
32247212-19453650-25241181 | 7023-7025 | 19453650 | denotes | 11 |
32247212-28831119-25241182 | 8630-8632 | 28831119 | denotes | 12 |
32247212-15897343-25241183 | 11626-11628 | 15897343 | denotes | 17 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
175 | 273-284 | Species | denotes | coronavirus | Tax:11118 |
176 | 225-233 | Disease | denotes | COVID-19 | MESH:C000657245 |
177 | 258-266 | Disease | denotes | COVID-19 | MESH:C000657245 |
178 | 346-356 | Disease | denotes | arrhythmia | MESH:D001145 |
179 | 360-381 | Disease | denotes | myocardial infarction | MESH:D009203 |
180 | 400-413 | Disease | denotes | heart failure | MESH:D006333 |
181 | 478-482 | Disease | denotes | MERS | MESH:D018352 |
192 | 1109-1140 | Gene | denotes | angiotensin-converting enzyme 2 | Gene:59272 |
193 | 1142-1146 | Gene | denotes | ACE2 | Gene:59272 |
194 | 1227-1231 | Gene | denotes | ACE2 | Gene:59272 |
195 | 1384-1388 | Gene | denotes | ACE2 | Gene:59272 |
196 | 1417-1421 | Gene | denotes | ACE2 | Gene:59272 |
197 | 1065-1075 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
198 | 1083-1088 | Species | denotes | human | Tax:9606 |
199 | 1370-1380 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
200 | 1046-1063 | Disease | denotes | myocardial injury | MESH:D009202 |
201 | 1474-1485 | Disease | denotes | lung injury | MESH:D055370 |
206 | 1780-1788 | Species | denotes | patients | Tax:9606 |
207 | 1506-1518 | Disease | denotes | inflammation | MESH:D007249 |
208 | 1541-1549 | Disease | denotes | COVID-19 | MESH:C000657245 |
209 | 1810-1818 | Disease | denotes | COVID-19 | MESH:C000657245 |
215 | 2021-2027 | Chemical | denotes | oxygen | MESH:D010100 |
216 | 1923-1941 | Disease | denotes | systemic infection | MESH:D007239 |
217 | 1955-1962 | Disease | denotes | hypoxia | MESH:D000860 |
218 | 1979-1998 | Disease | denotes | respiratory illness | MESH:D012140 |
219 | 2073-2090 | Disease | denotes | myocardial injury | MESH:D009202 |
224 | 2115-2134 | Disease | denotes | coronary thrombosis | MESH:D003328 |
225 | 2145-2157 | Disease | denotes | inflammation | MESH:D007249 |
226 | 2279-2300 | Disease | denotes | myocardial infarction | MESH:D009203 |
227 | 2343-2355 | Disease | denotes | inflammation | MESH:D007249 |
229 | 2505-2513 | Disease | denotes | COVID-19 | MESH:C000657245 |
241 | 2689-2692 | Gene | denotes | esp | Gene:148713 |
242 | 2697-2705 | Species | denotes | patients | Tax:9606 |
243 | 2821-2831 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
244 | 2855-2866 | Chemical | denotes | aldosterone | MESH:D000450 |
245 | 2643-2659 | Disease | denotes | systemic illness | MESH:D002908 |
246 | 2676-2687 | Disease | denotes | arrhythmias | MESH:D001145 |
247 | 2722-2738 | Disease | denotes | cardiac disorder | MESH:D006331 |
248 | 2774-2785 | Disease | denotes | hypokalemia | MESH:D007008 |
249 | 2789-2797 | Disease | denotes | COVID-19 | MESH:C000657245 |
250 | 2879-2890 | Disease | denotes | Hypokalemia | MESH:D007008 |
251 | 2926-2942 | Disease | denotes | tachyarrhythmias | MESH:D013610 |
262 | 535-545 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
263 | 581-597 | Species | denotes | beta-coronavirus | Tax:694002 |
264 | 622-640 | Species | denotes | beta-coronaviruses | Tax:694002 |
265 | 660-665 | Species | denotes | human | Tax:9606 |
266 | 882-892 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
267 | 666-676 | Disease | denotes | infections | MESH:D007239 |
268 | 708-724 | Disease | denotes | flulike symptoms | MESH:D051271 |
269 | 797-801 | Disease | denotes | MERS | MESH:D018352 |
270 | 818-826 | Disease | denotes | COVID-19 | MESH:C000657245 |
271 | 1020-1028 | Disease | denotes | COVID-19 | MESH:C000657245 |
293 | 2991-2999 | Species | denotes | patients | Tax:9606 |
294 | 3224-3232 | Species | denotes | patients | Tax:9606 |
295 | 3379-3387 | Species | denotes | patients | Tax:9606 |
296 | 4265-4273 | Species | denotes | patients | Tax:9606 |
297 | 3018-3021 | Disease | denotes | CVD | MESH:D002318 |
298 | 3073-3081 | Disease | denotes | COVID-19 | MESH:C000657245 |
299 | 3301-3310 | Disease | denotes | infection | MESH:D007239 |
300 | 3393-3401 | Disease | denotes | COVID-19 | MESH:C000657245 |
301 | 3447-3455 | Disease | denotes | diabetes | MESH:D003920 |
302 | 3457-3487 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
303 | 3492-3504 | Disease | denotes | hypertension | MESH:D006973 |
304 | 3550-3558 | Disease | denotes | diabetes | MESH:D003920 |
305 | 3563-3575 | Disease | denotes | hypertension | MESH:D006973 |
306 | 3656-3686 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
307 | 3746-3754 | Disease | denotes | diabetes | MESH:D003920 |
308 | 3756-3786 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
309 | 3791-3803 | Disease | denotes | hypertension | MESH:D006973 |
310 | 4122-4130 | Disease | denotes | COVID-19 | MESH:C000657245 |
311 | 4279-4291 | Disease | denotes | hypertension | MESH:D006973 |
312 | 4293-4301 | Disease | denotes | diabetes | MESH:D003920 |
313 | 4306-4309 | Disease | denotes | CVD | MESH:D002318 |
323 | 4639-4647 | Species | denotes | patients | Tax:9606 |
324 | 4890-4898 | Species | denotes | patients | Tax:9606 |
325 | 4909-4917 | Species | denotes | patients | Tax:9606 |
326 | 5085-5093 | Species | denotes | patients | Tax:9606 |
327 | 4781-4789 | Disease | denotes | diabetes | MESH:D003920 |
328 | 4811-4835 | Disease | denotes | congestive heart failure | MESH:D006333 |
329 | 4852-4871 | Disease | denotes | cardiac dysfunction | MESH:D006331 |
330 | 4918-4922 | Disease | denotes | died | MESH:D003643 |
331 | 4998-5004 | Disease | denotes | deaths | MESH:D003643 |
333 | 5203-5211 | Disease | denotes | COVID-19 | MESH:C000657245 |
335 | 5226-5243 | Disease | denotes | myocardial injury | MESH:D009202 |
341 | 5572-5590 | Gene | denotes | cardiac troponin I | Gene:7137 |
342 | 5592-5596 | Gene | denotes | cTnI | Gene:7137 |
343 | 5250-5267 | Disease | denotes | myocardial injury | MESH:D009202 |
344 | 5318-5326 | Disease | denotes | COVID-19 | MESH:C000657245 |
345 | 5398-5415 | Disease | denotes | myocardial injury | MESH:D009202 |
357 | 5837-5841 | Gene | denotes | cTnI | Gene:7137 |
358 | 6098-6102 | Gene | denotes | cTnI | Gene:7137 |
359 | 5997-6005 | Species | denotes | patients | Tax:9606 |
360 | 6248-6256 | Species | denotes | patients | Tax:9606 |
361 | 6284-6292 | Species | denotes | patients | Tax:9606 |
362 | 6480-6488 | Species | denotes | patients | Tax:9606 |
363 | 5718-5732 | Disease | denotes | cardiac injury | MESH:D006331 |
364 | 5939-5953 | Disease | denotes | cardiac injury | MESH:D006331 |
365 | 6038-6043 | Disease | denotes | death | MESH:D003643 |
366 | 6160-6174 | Disease | denotes | cardiac injury | MESH:D006331 |
367 | 6262-6270 | Disease | denotes | COVID-19 | MESH:C000657245 |
378 | 6642-6650 | Species | denotes | patients | Tax:9606 |
379 | 6955-6963 | Species | denotes | patients | Tax:9606 |
380 | 7107-7112 | Species | denotes | human | Tax:9606 |
381 | 6594-6617 | Disease | denotes | cardiac injury and rise | MESH:D006331 |
382 | 6656-6664 | Disease | denotes | COVID-19 | MESH:C000657245 |
383 | 6768-6785 | Disease | denotes | myocardial injury | MESH:D009202 |
384 | 6799-6810 | Disease | denotes | myocarditis | MESH:D009205 |
385 | 6837-6849 | Disease | denotes | inflammation | MESH:D007249 |
386 | 6972-6976 | Disease | denotes | died | MESH:D003643 |
387 | 7158-7175 | Disease | denotes | myocardial injury | MESH:D009202 |
400 | 7533-7541 | Species | denotes | patients | Tax:9606 |
401 | 7588-7596 | Species | denotes | patients | Tax:9606 |
402 | 7637-7645 | Species | denotes | patients | Tax:9606 |
403 | 7251-7272 | Disease | denotes | myocardial infarction | MESH:D009203 |
404 | 7276-7284 | Disease | denotes | COVID-19 | MESH:C000657245 |
405 | 7340-7377 | Disease | denotes | left ventricular systolic dysfunction | MESH:D018487 |
406 | 7385-7409 | Disease | denotes | left ventricular failure | MESH:D018487 |
407 | 7414-7431 | Disease | denotes | cardiogenic shock | MESH:D012770 |
408 | 7507-7520 | Disease | denotes | heart failure | MESH:D006333 |
409 | 7524-7532 | Disease | denotes | COVID-19 | MESH:C000657245 |
410 | 7547-7560 | Disease | denotes | Heart failure | MESH:D006333 |
411 | 7614-7618 | Disease | denotes | died | MESH:D003643 |
413 | 7693-7704 | Disease | denotes | Arrhythmias | MESH:D001145 |
420 | 7835-7843 | Species | denotes | patients | Tax:9606 |
421 | 7721-7738 | Disease | denotes | brady-arrhythmias | MESH:D001145 |
422 | 7761-7769 | Disease | denotes | COVID-19 | MESH:C000657245 |
423 | 7849-7857 | Disease | denotes | COVID-19 | MESH:C000657245 |
424 | 7886-7896 | Disease | denotes | arrhythmia | MESH:D001145 |
425 | 8042-8052 | Disease | denotes | arrhythmia | MESH:D001145 |
439 | 8212-8220 | Species | denotes | patients | Tax:9606 |
440 | 8347-8355 | Species | denotes | SARS-CoV | Tax:694009 |
441 | 8398-8408 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
442 | 8437-8445 | Species | denotes | patients | Tax:9606 |
443 | 8679-8687 | Species | denotes | patients | Tax:9606 |
444 | 8923-8931 | Species | denotes | patients | Tax:9606 |
445 | 8113-8121 | Disease | denotes | COVID-19 | MESH:C000657245 |
446 | 8497-8530 | Disease | denotes | abnormalities of lipid metabolism | MESH:D052439 |
447 | 8554-8570 | Disease | denotes | CV abnormalities | MESH:D018376 |
448 | 8595-8621 | Disease | denotes | altered glucose metabolism | MESH:D044882 |
449 | 8710-8738 | Disease | denotes | respiratory tract infections | MESH:D012141 |
450 | 8818-8826 | Disease | denotes | COVID-19 | MESH:C000657245 |
451 | 8944-8947 | Disease | denotes | CVD | MESH:D002318 |
456 | 9341-9349 | Species | denotes | patients | Tax:9606 |
457 | 9418-9426 | Species | denotes | patients | Tax:9606 |
458 | 9311-9319 | Disease | denotes | infected | MESH:D007239 |
459 | 9409-9417 | Disease | denotes | COVID-19 | MESH:C000657245 |
466 | 9721-9729 | Species | denotes | patients | Tax:9606 |
467 | 9880-9888 | Species | denotes | patients | Tax:9606 |
468 | 9990-9998 | Species | denotes | patients | Tax:9606 |
469 | 9712-9720 | Disease | denotes | COVID-19 | MESH:C000657245 |
470 | 9871-9879 | Disease | denotes | COVID-19 | MESH:C000657245 |
471 | 10260-10268 | Disease | denotes | COVID-19 | MESH:C000657245 |
477 | 10457-10465 | Species | denotes | patients | Tax:9606 |
478 | 11005-11013 | Species | denotes | patients | Tax:9606 |
479 | 11152-11160 | Species | denotes | patients | Tax:9606 |
480 | 10690-10699 | Disease | denotes | infection | MESH:D007239 |
481 | 11019-11027 | Disease | denotes | COVID-19 | MESH:C000657245 |
485 | 11298-11306 | Species | denotes | patients | Tax:9606 |
486 | 11312-11320 | Disease | denotes | COVID-19 | MESH:C000657245 |
487 | 11359-11380 | Disease | denotes | myocardial infarction | MESH:D009203 |
498 | 11434-11437 | Gene | denotes | ACE | Gene:1636 |
499 | 11572-11576 | Gene | denotes | ACE2 | Gene:59272 |
500 | 11657-11661 | Gene | denotes | ACE2 | Gene:59272 |
501 | 11637-11647 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
502 | 11681-11686 | Species | denotes | human | Tax:9606 |
503 | 11792-11800 | Species | denotes | patients | Tax:9606 |
504 | 12168-12175 | Species | denotes | patient | Tax:9606 |
505 | 11515-11523 | Disease | denotes | COVID-19 | MESH:C000657245 |
506 | 11746-11754 | Disease | denotes | COVID-19 | MESH:C000657245 |
507 | 12185-12193 | Disease | denotes | COVID-19 | MESH:C000657245 |
518 | 12950-12953 | Gene | denotes | esp | Gene:148713 |
519 | 12234-12242 | Species | denotes | patients | Tax:9606 |
520 | 12958-12966 | Species | denotes | patients | Tax:9606 |
521 | 12541-12552 | Chemical | denotes | chloroquine | MESH:D002738 |
522 | 12553-12571 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
523 | 12576-12588 | Chemical | denotes | azathioprine | MESH:D001379 |
524 | 12847-12858 | Chemical | denotes | chloroquine | MESH:D002738 |
525 | 12859-12877 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
526 | 12347-12362 | Disease | denotes | viral infection | MESH:D001102 |
527 | 12972-13000 | Disease | denotes | hepatic or renal dysfunction | MESH:D008107 |
533 | 9017-9025 | Species | denotes | patients | Tax:9606 |
534 | 9135-9142 | Species | denotes | patient | Tax:9606 |
535 | 9042-9050 | Disease | denotes | COVID-19 | MESH:C000657245 |
536 | 9105-9108 | Disease | denotes | CVD | MESH:D002318 |
537 | 9151-9159 | Disease | denotes | COVID-19 | MESH:C000657245 |